The proxy was filed on Aug 8th, then it was filed again on

New Post Public Reply Private Reply Replies (0) Message Board
investorxc
The proxy was filed on Aug 8th, then it was filed again on Sept.9th with an additional paragraph added under the "Reasons for the Reverse Stock Split" heading on page 23. This includes the sentence:

"The increase in the available authorized but unissued shares of the Company’s
common stock will also allow the Company to satisfy conversions of all outstanding convertible securities of the Company. The Company has over
the last 12 months entered into securities purchase agreements with investors for the sale of its Series E and Series H Preferred Stock and warrants."

I'm sure the SEC required them to add this in. But then they just filed anther revised proxy yesterday which now includes 5 pages of security descriptions not there before. No doubt this was another revision the SEC asked them to include.

At the and of the day, if they do another huge RS, the existing shareholders will be wiped out. But I don't think the toxics will be able to convert enough shares to be paid in full either. The price will drop immediately- there will be no buyers and within a few months we will be back at a few cents. This would still not solve AMBS' money issues. Even if the senior noteholders loaned another $2-3 million dollars. It would be at the same terms and AMBS would go through it in 6 months. They won't be able to raise any more money, the sp will be back in the gutter, still on the OTC and they will still own millions to the toxics. GC needs to take a stand now and hopefully as Fred said, he is working another plan to fix things. The partner may not want to pay much upfront, but GC would be better off giving up majority ownership of ESS if he had to, to get enough cash to take Magna out. The other toxics I think would cooperate if Magna was gone. The problem is no investors can loan money at reasonable terms as long as there is a floorless convertible in place, so Dustin Johns for example would have I'm sure done a decent loan but had no choice to make it floorless to keep Magna from wiping him out. I would love to know what is owed to Magna now- anyone have an idea?

They paid 11-12 million for ESS last year so even if they could just get half that back from the partner and not take a milestone payment, it might be enough to pay Magna off and rework the rest of the notes. Long term, with positive data in the trial, it will be easy to obtain good financing later. My worse fear is GC decides to take whatever cash the partner is offering, do a huge R/S,, then take some more cash from the seniors-it could get him to positive data, but wipe out the shareholders in the process.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Court Enforces Design Rights: AEKE Blocked in Germany

Updated Category News Views 7

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 2

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
PureHealth Research Spotlights Simpler Supplement Trends

Updated Category News Views 0

What's Steering the Supplement Ship? Well, if you're paying any attention to the supplement space, you might've noticed something curious: folks are ditching complicated concoctions for good old fashioned simplicity. PureHealth Research, out of Manassas, is throwing the limelight on this trend, where people are handing in their multi-ingredient cocktail for a single...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 2

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Tuya Smart's AI Innovations Steal the Spotlight at IFA

Updated Category News Views 1

AI Taking Center Stage at IFA 2026 Amidst the chaos of tech exhibitions, something caught my attention—Tuya Smart's push in making AI a household name. Now, you might wonder why I’m bringing this up. Well, because it's not your typical flashy gadget talk. This is about Tuya parading their latest breakthroughs like a peacock at the world's stage, IFA 2026 in Berlin,...

Continue Reading
MongoDB Preps for Key September Investor Conferences

Updated Category News Views 1

Gearing Up for September: MongoDB Targets Investors Folks in the investing world, circle some dates on your calendars. MongoDB, Inc. (NASDAQ: MDB) is taking the stage at three separate investor conferences this September. Why should we care? Because these are not just any old gigs—it's big names like Citi, Goldman Sachs, and Piper Sandler, and they happen to be perfect...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading

Top 5 Most Recently Viewed Articles

Heritage Commerce Corp Welcomes Christopher J. Abate to Board

Updated Category News Views 144

Heritage Commerce Corp Expands Leadership Team In a noteworthy development for the financial sector, Heritage Commerce Corp (NASDAQ: HTBK) has recently announced the appointment of Christopher J. Abate to its Board of Directors. This move enhances the leadership of the company as it continues to pursue its strategic objectives. Welcoming a New Board Member Christopher J....

Continue Reading
Echo IQ Limited Makes Major Strides with EchoSolv HF Validation

Updated Category News Views 220

Significant Milestone Achieved by Echo IQ for EchoSolv HF Echo IQ Limited (AUST: EIQ.AX), a leader in AI-driven medical technology, has successfully completed clinical validation for its innovative heart failure clinical decision support software, EchoSolv HF. This important achievement occurred in partnership with the distinguished Mayo Clinic, known for its high...

Continue Reading
Bristol Myers Squibb's Promising Progress in Multiple Myeloma

Updated Category News Views 278

Bristol Myers Squibb Advances in Multiple Myeloma Treatment Bristol Myers Squibb & Co. (NYSE: BMY) is making significant strides with its investigational treatment using iberdomide, a cutting-edge cereblon E3 ligase modulator (CELMoD). Recently, the company revealed promising results from the Phase 3 EXCALIBER-RRMM study, focusing on its effectiveness in combination with...

Continue Reading
AWP Safety Expands Reach with New Strategic Acquisitions

Updated Category News Views 487

AWP Safety Enhances Market Presence AWP Safety, recognized as a leader in safety and traffic management solutions, has taken a significant step forward by acquiring three regional traffic control companies: Site Barricades, Integrity Traffic, and WS Barricade. This strategic move aims to broaden AWP Safety's operational footprint and bolster its status as a preferred...

Continue Reading
Innovative Bait Cup Encourages Eco-Friendliness in Fishing

Updated Category News Views 133

Embracing Eco-Friendly Solutions in Fishing In a world increasingly aware of environmental concerns, the introduction of reusable products is vital. An inventive spirit has emerged in the fishing community, addressing the problem of disposable bait cups. An inventor passionately remarked on their love for fishing and deep concern over litter in natural habitats. This led...

Continue Reading